Paris-based AI software developer Gleamer has formed a strategic partnership with ConcertAI subsidiary TeraRecon.
As a result, TeraRecon will integrate Gleamer's BoneView (FDA-cleared and CE-marked versions) and ChestView software into its Eureka Clinical AI platform. BoneView has received regulatory clearance in the U.S. and Europe and is designed to identify bone fractures on x-rays, while ChestView is cleared in Europe and is designed to detect pulmonary nodules on x-rays, according to the vendors.
